Advertisement
Grab your lab coat. Let's get started
Welcome!
Welcome!
Create an account below to get 6 C&EN articles per month, receive newsletters and more - all free.
It seems this is your first time logging in online. Please enter the following information to continue.
As an ACS member you automatically get access to this site. All we need is few more details to create your reading experience.
Not you? Sign in with a different account.
Not you? Sign in with a different account.
ERROR 1
ERROR 1
ERROR 2
ERROR 2
ERROR 2
ERROR 2
ERROR 2
Password and Confirm password must match.
If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)
ERROR 2
ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.
December 5, 2016 Cover
Volume 94, Issue 48
Millionaires, mergers, mosquitos, and more made for big stories in 2016
Cover image:
Pharma year in review
Millionaires, mergers, mosquitos, and more made for big stories in 2016
Cautious optimism for an HIV vaccine
Largest clinical trial in seven years to test the efficacy of an HIV vaccine is kicking off in South Africa
PPG counts on chemistry to give it an edge
Under Chief Technology Officer David Bem, a growing research force leverages acquisitions and technology to invent new paints
-
Perspectives: When are industries judged fairly?
In seeking to understand how people rate risks, psychologists break the big question down into many small ones
-
Big pharma and biotech pour into Cambridge, England
Among the city’s growing pains, housing costs are rising and laboratory space is becoming tight
-
Teaching aryl Grignards new synthetic tricks
Classic organometallic reagent reacts with bench-stable oxaziridines to forge C–N and C–O bonds
ADVERTISEMENT
Science Concentrates
Polymer reduces drug conjugate immune reactions
Substitute for polyethylene glycol enhances performance of existing immune-hindered drugs
